Indivior Pharmaceuticals (INDV) Short-term Investments (2022 - 2025)

Indivior Pharmaceuticals has reported Short-term Investments for 4 years, with the latest figure at $1.0 million in Q1 2025.

• On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.0 million in Q1 2025; TTM through Mar 2025 was $1.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.0 million, down 99.76% from the prior year.
• Short-term Investments was $1.0 million for Q1 2025 at Indivior Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
• The five-year high for Short-term Investments was $415.0 million in Q4 2023, with the low at $1.0 million in Q4 2024.
• Average Short-term Investments over 4 years is $134.0 million, with a median of $60.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments soared 248.74% in 2023, then tumbled 99.76% in 2024.
• Over 4 years, Short-term Investments stood at $119.0 million in 2022, then jumped by 248.74% to $415.0 million in 2023, then sank by 99.76% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
• The last three Short-term Investments figures came in at $1.0 million (Q1 2025), $1.0 million (Q4 2024), and $415.0 million (Q4 2023), per Business Quant data.